⚡️PNEUMOVAS⚡️ 💉reinforced anti pneumococcal vaccine in AAV pts on Rituximab💉 👉Reinforced regimen (double dose PCV13 D0/D7 wt PPV23 @ M5) - sig ⬆️ Ab response 2 strep pneum ❓application 2 👉other vaccines 👉 other RTX tx IMRD #ACR22 AbstL16 @RheumNow @TerrierBen https://t.co/BnZWAoHDj6

Maksymowych et al. RCT ofAdalimumab for knee OA!? it doesn't work. @RheumNow #ACR22 Abstr#1891 https://t.co/pfPVJ9A1Ex https://t.co/X7sLEaqGvT

• Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab: A Rando…

@RheumNow video live from #ACR22 Ab0675: Diffuse alveolar hemorrhage in APLS https://t.co/8BDyxzAGJ2

What’s new w #classification for #APS? You don’t have to have 2 positive tests disseminated in time. BUT remember the the labs for anticardiolipin are shockingly variable btwn centres. @RheumNow #ACR22 https://t.co/NTqQ6h7fws

• https://twitter.com/ericdeinmd/status/1592017355458379776

Abstract #PP25 Patient mantra on life with SpA: “not to over-exert the body on your good days and always strive to be active on your bad days” Patient recommended exercise: 🏓table tennis 🏊‍♂️swimming 🧘yoga 🤸tai chi #ACR22 @RheumNow

Staggering stats after a #osteoporosis hip fracture! 40% cannot walk independently 30% have a permanent disability 20% mortality in surgically fixed hip 40% mortality if not surgically fixed. -Dr. M Humphrey #ACR22 @rheumnow https://t.co/DSYQjDw6pW

Dose Matters! Steroid doses as little as 2.5 mg/day when taken chronically increase risk for fractures #ACR22 @rheumnow https://t.co/fIocJtebkI

Morales et al. AUR200, novel BAFF/APRIL inhibitor. Looking promising in pre-clinical and animal models. We will wait and see! @RheumNow #ACR22 Abstr#1629 https://t.co/htmX2GHV3X https://t.co/jvhFdx2c52

• AUR200: An Improved BAFF/APRIL Inhibitor with Increased Potency and Safety for …

MOA of how steroids cause #osteoporosis #ACR22 @rheumnow https://t.co/k6MvftH4AV

Lin et al. Genetic risk (HR 2.3 women, 2.63 men) and lifestyle (HR 5.7 for women, 3.7 for men) both individual contributors and synergistic (HR 9.1 women, 8.7 men) in gout development in both men and women. Modifiable! @RheumNow #ACR22 Abstr#1633 https://t.co/51KPgfXn1w https://t.co/gOU7DfOKvt

• Genetic Risk, Adherence to a Healthy Lifestyle, and Incident Gout in US Women a…

PMR is no a disease of vague shoulder and hip pain. It's something much more specific: a chronic inflammatory disease of musculotendinous structures. We're starting to understand the real story. @drceowen lays it out for #ACR22 this morning @EBRheum @SattuiSEMD @RheumNow https://t.co/thqtCwSULM

Bimekizumab (BKZ) in AxSpA to Wk52 ◦ sustained efficacy ◦ suppression of inflammation ◦ improvements in function and quality of life ◦ no new safety signals were observed ◦ consistent with the safety profileWk24 data Baraliakos #L14 https://t.co/gk23g4vqQl #ACR22 @RheumNow

• Bimekizumab Maintains Improvements in Efficacy Endpoints and Has a Consistent S…

Fernandes et al. CPPD assoc increased nephrolithiasis. 8.06% vs 4.88%; p<0.0001. @RheumNow #ACR22 Abstr#1819 https://t.co/o8Afmcc429 https://t.co/3EoOXpqpGN

• Calcium Pyrophosphate Deposition Disease Is Associated with an Increased Preval…

Chen et al. Appendicitis associated increased risk incident SLE in population-based case-control study from Taiwan. HR 2.04 @RheumNow #ACR22 Abstr#1750 https://t.co/L9dTpMdHNP https://t.co/mEHeL6JnuE

• Association Between Appendicitis and the Risk of Systemic Lupus Erythematosus: …

Parperis et al. Cypriot population based study. ACS in CPPD assoc longer LOS, and increased mortality 6.9% vs 5.6% (p<0.001). @RheumNow #ACR22 Abstr#1817 https://t.co/uWv67aZa9L https://t.co/3oRFXREcYx

• Acute Coronary Syndrome in Calcium Pyrophosphate Deposition Disease Patients: A…